BRONCHICINE
® CAe
Pfizer Animal Health
Bordetella Bronchiseptica Bacterin
Cellular Antigen Extract
Bronchicine CAe is for vaccination of healthy dogs 8 weeks of age or older as an aid in the control of canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica. Bronchicine CAe is a nonadjuvanted antigenic extract prepared from the cells of B. bronchiseptica.
Directions: Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 2-4 weeks apart. Annual revaccination with a single dose is recommended.
The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to the bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica in dogs.
Precautions: Store at 2°-7°C). Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Transient local irritation at the site of injection, though rare, may occur subsequent to use of this product. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
Technical inquiries should be directed to Pfizer Animal Health Veterinary Services, (800) 366-5288 (USA).
U.S. Veterinary License No. 189
Pfizer Animal Health, Exton, PA 19341, USA, Div. of Pfizer Inc, NY, NY 10017
3543000
10193700
Presentation: 25 1-dose (1-mL) and 5 10-dose (10-mL) vials of bacterin.
NAC No.: 36902321